These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31182540)

  • 1. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis
    Kebriaei R; Rice SA; Stamper KC; Seepersaud R; Garcia-de-la-Maria C; Mishra NN; Miro JM; Arias CA; Tran TT; Sullam PM; Bayer AS; Rybak MJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
    Escrihuela-Vidal F; Fernández-Hidalgo N; Muñoz P; Villamarín M; Jiménez García N; Escudero EM; Martínez Marcos FJ; Cuervo G; Boix-Palop L; Berbel D; Carratalà J; Miró JM
    J Antimicrob Chemother; 2024 Oct; ():. PubMed ID: 39351977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis
    Mishra NN; Abdelhady W; Elsayed AM; Lapitan C; Proctor RA; Rybak MJ; Miro JM; Bayer AS
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0147222. PubMed ID: 36877026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced heterogeneity observed in high-level daptomycin-resistant viridans group streptococci.
    Akins RL; Barber KE; Palmer KL
    J Glob Antimicrob Resist; 2016 Dec; 7():159-166. PubMed ID: 27835845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
    Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
    Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
    Yim J; Smith JR; Singh NB; Rice S; Stamper K; Garcia de la Maria C; Bayer AS; Mishra NN; Miró JM; Tran TT; Arias CA; Sullam P; Rybak MJ
    J Antimicrob Chemother; 2017 Aug; 72(8):2290-2296. PubMed ID: 28475731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of High-Level Daptomycin Resistance in
    Cañas MA; Téllez A; García de la Mària C; Dahl A; García-González J; Hernández-Meneses M; Almela M; Ambrosioni J; Falces C; Quintana E; Vidal B; Perissinotti A; Tolosana JM; Sandoval E; Pericàs JM; Moreno A; Miró JM;
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0252220. PubMed ID: 34252304
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis.
    Süzük S; Kaşkatepe B; Çetin M
    Infez Med; 2016 Sep; 24(3):190-3. PubMed ID: 27668898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam antibiotics and viridans group streptococci.
    Lopardo HA; Vigliarolo L; Bonofiglio L; Gagetti P; García Gabarrot G; Kaufman S; Mollerach M; Toresani I; von Specht M
    Rev Argent Microbiol; 2022; 54(4):335-343. PubMed ID: 36266147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.
    Akins RL; Katz BD; Monahan C; Alexander D
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2102-12. PubMed ID: 25624330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C; Xiong YQ; Pericas JM; Armero Y; Moreno A; Mishra NN; Rybak MJ; Tran TT; Arias CA; Sullam PM; Bayer AS; Miro JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
    Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
    Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L
    J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.